Therefore, understanding the underlying mechanisms of how intrinsic IL-33/Il1rl1 signaling induces LSCs to undergo self-renewal could provide a specific therapeutic strategy for AML stem cells. The gene discussed is IL1RL1; the disease is acute myeloid leukemia.